(P-1515) The Socioeconomic Value of Adult Respiratory Vaccination in the United States: A Benefit-Cost Analysis

Tuesday, October 21, 2025

12:15 PM - 1:30 PM US ET

Location: Poster Hall B4-B5

Presenting Author(s)

MN

Matthew W. Napier, MSc Health Economics and Health Policy

Economist
Office of Health Economics
London, England, United Kingdom
Alon Yehoshua, PharmD, MS

Director, HTA Value and Evidence
Pfizer Inc.
New York, New York, United States
JV

Jeffrey T. Vietri, PhD

Director, HTA, Value, & Evidence
Pfizer, Inc.
Collegeville, PA, United States
CT

Claud Theakston, MSc

Economist
Office of Health Economics
London, England, United Kingdom
SC

Sulayman Z. Chowdhury, MSc

Office of Health Economics
London, England, United Kingdom
DM

Diana Mendes, PhD

Pfizer Ltd.
Tadworth, England, United Kingdom
SB

Simon Brassel, MSc, Dipl.-Ing.

Office of Health Economics
London, England, United Kingdom
Raymond Farkouh, PhD

Vaccines Health Economics and Outcomes Research
Pfizer, Inc.
Collegeville, Pennsylvania, United States
LS

Lotte Steuten, MSc, PhD

Office of Health Economics
London, England, United Kingdom